Cardlytics Inc. logo

Cardlytics Inc. (CDLX)

Market Open
23 Jul, 13:32
NASDAQ (NMS) NASDAQ (NMS)
$
2. 85
+0.82
+40.39%
$
106.58M Market Cap
- P/E Ratio
0% Div Yield
15,164,600 Volume
-0.39 Eps
$ 2.03
Previous Close
Day Range
2.17 3.06
Year Range
1.22 9.48
Want to track CDLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 5 days
Shareholders that Lost Money on Cardlytics, Inc. (CDLX) Should Contact Levi & Korsinsky About Securities Fraud Investigation - CDLX

Shareholders that Lost Money on Cardlytics, Inc. (CDLX) Should Contact Levi & Korsinsky About Securities Fraud Investigation - CDLX

NEW YORK, NY / ACCESSWIRE / September 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.

Accesswire | 10 months ago
Cardlytics Inc May Have Defrauded Investors And Those With Losses Should Join The Schall Law Firm's Inquiry

Cardlytics Inc May Have Defrauded Investors And Those With Losses Should Join The Schall Law Firm's Inquiry

LOS ANGELES, CA / ACCESSWIRE / September 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 10 months ago
An Investigation Has Commenced on Behalf of Cardlytics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your CDLX Losses.

An Investigation Has Commenced on Behalf of Cardlytics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your CDLX Losses.

NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.

Accesswire | 10 months ago
The Schall Law Firm Is Looking Into Whether Cardlytics, Inc. Committed Securities Law Violations And Stockholders Are Invited To Take Part

The Schall Law Firm Is Looking Into Whether Cardlytics, Inc. Committed Securities Law Violations And Stockholders Are Invited To Take Part

LOS ANGELES, CA / ACCESSWIRE / September 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 10 months ago
Levi & Korsinsky Reminds Shareholders of an Investigation into Cardlytics, Inc. (CDLX) Regarding Potential Securities Fraud Allegations

Levi & Korsinsky Reminds Shareholders of an Investigation into Cardlytics, Inc. (CDLX) Regarding Potential Securities Fraud Allegations

NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.

Accesswire | 10 months ago
Levi & Korsinsky Reminds Cardlytics Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CDLX

Levi & Korsinsky Reminds Cardlytics Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CDLX

NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.

Accesswire | 10 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX

NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Accesswire | 10 months ago
Cardlytics Inc May Have Defrauded Investors And Those With Losses Should Contact The Schall Law Firm About An Investigation

Cardlytics Inc May Have Defrauded Investors And Those With Losses Should Contact The Schall Law Firm About An Investigation

LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 10 months ago
ATTENTION CDLX SHAREHOLDERS: Investors Who Lost Money on Cardlytics, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation

ATTENTION CDLX SHAREHOLDERS: Investors Who Lost Money on Cardlytics, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation

NEW YORK, NY / ACCESSWIRE / September 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.

Accesswire | 10 months ago
Investors With Losses In Cardlytics Inc Are Encouraged To Contact The Schall Law Firm About An Investigation Into Possible Securities Fraud

Investors With Losses In Cardlytics Inc Are Encouraged To Contact The Schall Law Firm About An Investigation Into Possible Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 10 months ago
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CDLX

Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CDLX

NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.

Accesswire | 10 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX

NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Accesswire | 10 months ago
Loading...
Load More